CINECA IRIS Institutional Research Information System

GIRAUDO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.329
EU - Europa 3.266
AS - Asia 1.823
AF - Africa 58
OC - Oceania 22
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 9.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.251
CN - Cina 1.172
IT - Italia 1.029
IE - Irlanda 313
DE - Germania 305
SE - Svezia 266
FR - Francia 263
GB - Regno Unito 216
UA - Ucraina 177
FI - Finlandia 160
JP - Giappone 129
AT - Austria 116
KR - Corea 111
DK - Danimarca 100
PL - Polonia 83
VN - Vietnam 80
CA - Canada 70
IN - India 62
HK - Hong Kong 53
SG - Singapore 50
BE - Belgio 48
SN - Senegal 44
NL - Olanda 39
ES - Italia 38
CH - Svizzera 34
TW - Taiwan 33
IL - Israele 31
TR - Turchia 23
AU - Australia 19
IR - Iran 19
RO - Romania 14
TH - Thailandia 14
RU - Federazione Russa 13
GR - Grecia 11
HU - Ungheria 11
EU - Europa 9
ID - Indonesia 8
PK - Pakistan 8
BR - Brasile 7
MX - Messico 7
AE - Emirati Arabi Uniti 6
AR - Argentina 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
PT - Portogallo 5
ZA - Sudafrica 5
CO - Colombia 4
HR - Croazia 4
LT - Lituania 4
NO - Norvegia 4
AM - Armenia 3
CL - Cile 3
EG - Egitto 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
CI - Costa d'Avorio 2
DZ - Algeria 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
RS - Serbia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 9.528
Salva come PNG Salva come JPEG
Città #
Chandler 501
Beijing 379
Ann Arbor 359
Dublin 310
Torino 295
Fairfield 259
Houston 223
Ashburn 165
Woodbridge 151
Dearborn 147
Jacksonville 146
Wilmington 135
Villeurbanne 129
Seattle 128
Nyköping 113
Vienna 113
Redwood City 103
Shanghai 100
Cambridge 97
Princeton 95
Medford 91
Guangzhou 90
Pisa 81
Milan 74
Warsaw 62
Hangzhou 59
Fremont 55
Nanjing 53
Dong Ket 46
Boston 44
Turin 39
Wuhan 36
Brussels 33
Rome 33
Tokyo 33
San Diego 27
Boardman 25
Los Angeles 25
Jinan 24
London 23
Hefei 22
Taipei 22
Singapore 21
Changsha 19
Helsinki 18
New York 18
San Francisco 18
Central 17
Xian 17
Norwalk 16
Chengdu 15
Menlo Park 15
Ottawa 15
Paris 15
Phoenix 15
Falls Church 14
Dallas 13
Tianjin 13
Zhengzhou 13
Central District 12
Fuzhou 12
Hebei 12
Silver Spring 12
Toronto 12
Verona 12
Frankfurt am Main 11
Herzliya 11
Kunming 11
Chicago 10
Munich 10
Bethesda 9
Chongqing 9
Leiden 9
Luni 9
Nanchang 9
Simi Valley 9
Barcelona 8
Birmingham 8
Cincinnati 8
Duncan 8
Istanbul 8
Lanzhou 8
Philadelphia 8
Pittsburgh 8
Rehovot 8
Shenzhen 8
Viterbo 8
Zurich 8
Columbus 7
Créteil 7
Florence 7
Harbin 7
Jakarta 7
Melbourne 7
Riverside 7
Toulouse 7
Amsterdam 6
Copenhagen 6
Epsom 6
Irvine 6
Totale 5.572
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.682
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 590
Semaphorins in cardiovascular medicine. 262
Regulation of HMGCoA reductase Activity by Policosanol and Octacosadienol, a New synthetic Analogue of Octacosanol 258
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM 242
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 216
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 215
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 195
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE 190
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 188
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 187
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 181
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 158
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation 149
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 148
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 146
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 143
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 143
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 141
The role of semaphorins and their receptors in vascular development and cancer 131
Class 3 semaphorins in cardiovascular development 127
Effect of inhibiting the sterol biosynthesis pathway and the cholesterol content in the regulation of angiogenesis in vitro and in vivo 110
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 110
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 106
Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. 104
Biological aspects of tumour angiogenesis 100
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 100
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 97
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 94
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 88
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 88
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 84
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 84
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 79
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 77
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 77
Semaphorins and tumor angiogenesis 75
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 75
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 71
Class 3 semaphorin in angiogenesis and lymphangiogenesis 70
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 70
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. 70
Medical use of combinations of non-natural semaphorins 3 and antimetabolites 70
In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis. 67
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 66
A novel population of neuropilin-1-expressing mononuclear cells (NEMs) contributes to tumor vessel stabilization and normalization 64
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 64
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 64
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer 63
Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer 63
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 62
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 61
Modeling the early stages of vascular network assembly. 60
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 60
Zoledronic acid inhibit angiogenesis and impairs tumorigenesis in a mouse model of cervical carcinogenesis 60
Percolation, morphogenesis, and burgers dynamics in blood vessels formation. 59
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 58
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis 57
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 56
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 56
Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. 54
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. 54
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 54
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 53
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers 50
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 50
Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. 49
Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility. 49
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 49
Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. 49
Targeted nanoparticles for pancreatic cancer. 48
Lymphatic zip codes in premalignant lesions and tumors 46
Squalenic nanoparticles with active targeting: in vivo results 46
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 46
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 46
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. 45
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma 44
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 44
Nanoparticles targeting pancreatic tumor. 42
Targeted nanoparticles for pancreatic cancer. 41
Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 40
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 36
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 33
New human dihydroorotate dehydrogenase inhibitors able to restore myeloid differentiation in AML 32
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front 29
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 24
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 12
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 11
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 10
Breast cancers as ecosystems: a metabolic perspective 7
PlexinB1 deficiency in the microenvironment inhibits tumor growth and metastatic dissemination in mouse models of triple negative breast cancer 7
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 5
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer 1
Totale 9.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.315
article - articoli 0
book - libri 0
conference - conferenze 6.624
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019275 0 0 0 0 0 0 0 0 0 0 175 100
2019/20201.390 62 54 70 153 107 221 145 117 146 132 104 79
2020/20211.495 95 81 76 97 183 117 124 74 156 148 152 192
2021/20221.628 118 105 102 124 98 115 96 103 90 132 311 234
2022/20231.845 159 170 64 163 161 403 163 121 175 70 120 76
2023/20241.076 123 176 94 115 99 92 87 95 27 88 80 0
Totale 9.837